EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia ,

ISSN 2394-3211

Impact Factor: 7.065

ICV - 79.57

Abstract

SUSTAINED DRUG DELIVERY SYSTEM – A REVIEW

Sagar S. Dalvi*, Dr. Santosh B. Dighe and Dr. Sanjay B. Bhawar

ABSTRACT

Modified release drug delivery systems are those that release a drug over a long period of time. Israel Lipowski's 1938 patent for drug delivery dosage forms was a precursor to sustained release. The benefits of sustained release are to prolong the effects of a drug and to reduce the need for repeated dosing. Additionally, these candidates are unsuitable for SRDDS. Plasma concentration response relationship: In most situations, plasma drug concentration rather than dose is more essential for pharmacological activity. However, medicines with pharmacological activity unrelated to plasma concentrations are poor candidates for oral SR drug delivery systems. Concentration dependency on transfer of drug: Such drugs are poor candidates for oral SR delivery methods if the drug has been transferred from one compartment to another using a zero order kinetic process. It should be kinetically first order.

Keywords: Sustained Release, Polymers, Matrix, Drug Delivery.

[Full Text Article] [Download Certificate]